Abstract
Objectives A positive response around 4.6 ms latency (IV’ wave) was observed at high intensity level in the ears which were always diagnosed with cochlear nerve deficiency (CND). This study is aimed to investigate the relationship between the IV’ wave and CND.
Study Design Retrospective study.
Setting Tertiary hospital
Methods The raw Auditory Brainstem Response data and inner ear images of the infants were reviewed. Data were analyzed by ear and the CND ears were further divided into the IV’ wave present and IV’ wave absent group. The distortion product otoacoustic emissions (DPOAE) and auditory steady-state response (ASSR) results were compared between the two groups.
Results In total, 570 ears were included. There were 129 ears diagnosed with CND and the IV’ wave was observed in 52 ears. The latency of the IV’ wave averaged 4.60 ms at 95 dB. The positive predictive value of the IV’ wave for CND was 98.1%. The incidence of the IV’ wave in the CND is highly unlikely to occur by chance. The differences of the DPOAE amplitude between the two groups were not significant. The ASSR results of the IV’ wave present group was significantly better.
Conclusions Our study demonstrated a 4.6 ms positive response at high intensity level in the infants. The IV’ wave showed an excellent positive predictive value for CND. The extrapolated thresholds of the IV’ wave present group were better. The IV’ wave is expected to be a new indicator for the CND infants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the National Natural Science Foundation of China (grant 81700903 to BL), Clinical Research Plan of SHDC (shdc12020105) and Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This was a retrospective study, and it was approved by the Translational Medicine Ethics Review Committee of Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine (SH9H-2022-T378-1).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial disclosures/conflicts of interest: This work was supported by grants from the National Natural Science Foundation of China (grant 81700903 to BL), Clinical Research Plan of SHDC (shdc12020105) and Shanghai Key Laboratory of Translational Medicine on Ear and Nose Diseases (14DZ2260300).
Figure 3,4,5 revised;author updated;
Data Availability
All data produced in the present work are contained in the manuscript
